Evidence synthesis and analytics

Payers ask how a treatment compares with every relevant alternative, including those it was never tested against. We answer with direct and indirect comparisons that handle uncertainty openly.

Where trials share comparators, we pool them with meta-analysis and network meta-analysis. Where trial populations differ, we use population-adjusted methods: matching-adjusted indirect comparison (MAIC) and simulated treatment comparison (STC).

We also run the analyses that feed economic models and value stories: survival analysis and extrapolation, utility mapping, and analysis of clinical trial and patient-reported outcome data.

What we deliver

  • Meta-analysis (MA) and network meta-analysis (NMA)
  • Matching-adjusted indirect comparison (MAIC)
  • Simulated treatment comparison (STC)
  • Survival analysis and extrapolation
  • Utility mapping
  • Clinical trial and patient-reported outcome (PRO) analysis

Related publications from our team

Browse all publications

Common questions

When is a network meta-analysis needed?

When payers need to know how a treatment compares with alternatives that it has not been tested against directly. A network meta-analysis combines direct and indirect evidence across trials that share common comparators.

What is the difference between MAIC and STC?

Both adjust for differences between trial populations when comparing treatments indirectly. A matching-adjusted indirect comparison reweights individual patient data from one trial to match the published characteristics of another. A simulated treatment comparison uses a regression model to predict outcomes in the other trial's population.

What is utility mapping?

Utility mapping converts scores from a disease-specific or other non-preference-based questionnaire into health state utility values, such as EQ-5D, when the trial did not collect them directly. Those values are needed to calculate quality-adjusted life years.

Patients should not be left waiting for treatments that can change their lives.

We are committed to a healthcare system where value is measured fairly and decisions are guided by sound evidence. Tell us what you are working on and we will show you how we would approach it.